All articles by Robert Barrie

Robert Barrie

Robert Barrie is a trainee reporter for Medical Device Network, covering developments in the healthcare sector. Coming from a scientific and medical background, Robert has reported across various topics with expertise in neuroscience, genetics, and epidemiology. Previously, he worked on a freelance basis with New Scientist.

Do not use smartwatches to measure glucose levels, FDA says

Devices that claim to non-invasively measure blood sugar are illegally marketed, the US agency states.

BiVACOR secures $13m for total artificial heart programme

The funding will support clinical trials slated to commence in H1 2024 and develop the device’s wireless power source.

Medtronic exits “unprofitable” ventilator market

Current North America and Europe market leader drops ventilator product lines, pivots to form Acute Care and Monitoring business.

Werfen secures CE mark for antiphospholipid syndrome assays

Werfen’s reagents can be used to diagnose primary and secondary antiphospholipid syndrome in conjunction with other lab tests.

Kerecis expands fish-skin wound treatment range

The Shield Standard joins Kerecis’ Shield product range to treat severe ulcers and surgical wounds.

What does the future of brain-computer interfaces look like?

Amid ongoing human clinical trials, there is still a long way to go before neural chips are commonplace in clinics.

UroMems champions positive results for stress urinary incontinence implant

The French company has reported the first female patient implanted with the automated device met the trial’s primary endpoint.

ZKR Orthopedics secures IDE approval for LIFT implant US trial

The company’s implant will be tested in around 245 patients with later stage patellofemoral cartilage degeneration.

Pancake day injuries: the latest innovations in treating burns

The NHS outlines the important steps to be taken in case of a mishap, which include a visit to the hospital if the burn is severe enough.

Helping advance earlier CTE diagnosis in NFL players

The neurodegenerative disease is still mainly diagnosed after death, but advancements could help catch it earlier in living sports players.